Careers  |  Sign In  |  Register  |   Twitter

Latest in Rheumatology

Reuters Health • The Doctor's Channel Daily Newscast

Adalimumab may be superior to infliximab in childhood uveitis

NEW YORK (Reuters Health) – In children with chronic uveitis, adalimumab appears more effective than infliximab in maintaining remission, according to a small cohort study by Italian investigators. Should these results hold up in randomized controlled trials, Dr. Gabriele Simonini told Reuters Health...

Reuters Health • The Doctor's Channel Daily Newscast

Starting rituximab with methotrexate has benefits in early RA

NEW YORK (Reuters Health) – When patients with early active rheumatoid arthritis (RA) start rituximab along with methotrexate (MTX), they have significantly better physical function and health-related quality of life a year later than if they had taken MTX alone, a new study shows. Rituximab is indicated...

Reuters Health • The Doctor's Channel Daily Newscast

Abatacept effective for psoriatic arthritis

NEW YORK (Reuters Health) – The selective T-cell co-stimulation modulator abatacept safely and effectively treats psoriatic arthritis (PsA) in many patients, according to a report in the December 2nd online issue of Arthritis & Rheumatism. “Abatacept yields moderate effectiveness for treating the...